Formulation development and evaluation for intranasal L-dopa microsponge targeting brain for Parkinson’s disease

Documenti analoghi

• Brain-targeted nanocarriers intranasal formulation for migraine
  di: Ishant Kataria
• Development and Evaluation of Intranasal Formulation of Galantamine Hydrobromide for Alzhemier's Disease
  di: Yukta Kamat
• Development and evaluation of intranasal liposomal formulation of Memantine for Alzheimer’s disease
  di: Pallak Thakkar
• Intranasal Nanoparticle Based Delivery of Telmisartan for Brain Targeting : Formulation Development and Invivo Evaluation
  di: Ganti Srikar
• Development and Evaluation of Transferosomal Intranasal In-situ gel of Telmisartan for Brain Targeting
  di: Kuber Binalkumari